Carmine Gianatiempo, MD
Critical Care Medicine · Englewood, NJNPI 1558310748
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Covidien LP at 42.0% of the total. Reporting peaked in 2019 at $3,211 and has fallen 71.8% since, to $905 in 2025. Among critical care medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $116.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$3K
- La Jolla Pharmaceutical Company$2K
- BD$800
- ZOLL Medical Corporation$245
- Abiomed$186
- Cumberland Pharmaceuticals, Inc.$152
- plus $629 from 15 others
What the payments were for
- Speaking & faculty fees$2,47037%
- Travel & lodging$2,39436%
- Food & beverage$1,75727%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 7 | $2,783 |
| La Jolla Pharmaceutical Company | 4 | $1,826 |
| BD | 1 | $800 |
| ZOLL Medical Corporation | 1 | $245 |
| Abiomed | 3 | $186 |
| Cumberland Pharmaceuticals, Inc. | 10 | $152 |
| AbbVie(2 entities) | 3 | $133 |
| Chiesi USA, Inc. | 8 | $113 |
| Merck | 5 | $89 |
| Nuwellis, Inc. | 1 | $72 |
| CSL Behring | 3 | $46 |
| Pacira Pharmaceuticals Incorporated | 2 | $33 |
| Edwards Lifesciences | 1 | $32 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Grifols USA, LLC | 1 | $15 |
| Amgen | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Baudax Bio Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
| Acelrx Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puritan Bennett$1,918
- GIAPREZA$1,787
- Nellcor$712
- Impella$137
- AVYCAZ$110
How this compares
$6,621 in reported general payments places this provider in the 90th percentile of 254 critical care medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Englewood
- Fariborz RezaiLivingston$2.3M
- Eric TellerHackensack$217K
- R Phillip DellingerCamden$74K
- Raghad SaidHackensack$48K
- Neha VagadiaMarlton$31K
- Mark RamzyWest Orange$31K
- Shawana HussainCamden$19K
- Theodore PlushCamden$18K
- Martin LansangFlemington$18K
- Stephen TrzeciakCamden$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.